SCHEMBL6964290

SCHEMBL6964290

CC(C)CC(SC1CCCCC1)c1c(O)cc(-c2ccc3c(c2)OCCO3)oc1=O

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.40
ALDH1A1 P00352 4/20 0.38
NPSR1 Q6W5P4 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 2/20 0.38
HPGD P15428 1/20 0.38
MAPT P10636 3/20 0.35
ALOX5 P09917 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954759 0.87 ALDH1A1 (0.36) HTTALDH1A1NPSR1NPC1RAB9A
SCHEMBL6960131 0.86 ABCB1 (0.39) SMN1; SMN2
SCHEMBL6953451 0.85 SMN1; SMN2 (0.39) ALDH1A1KDM4ESMN1; SMN2HSD17B10TP53
SCHEMBL6965574 0.81 ALDH1A1 (0.42) ALDH1A1NPSR1NPC1RAB9AKDM4E
SCHEMBL9056635 0.80 ALDH1A1 (0.38) ALDH1A1NPSR1NPC1RAB9AKDM4E
SCHEMBL7374783 0.75 HTT (0.38) HTTALDH1A1NPSR1NPC1RAB9A
SCHEMBL7410547 0.74 ALDH1A1 (0.34) ALDH1A1NPSR1NPC1RAB9AKDM4E
SCHEMBL6954821 0.73 POLB (0.38) SMN1; SMN2MAPTLMNA
SCHEMBL6953834 0.73 SMN1; SMN2 (0.39) ALDH1A1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL6956156 0.73 SMN1; SMN2 (0.39) ALDH1A1KDM4ESMN1; SMN2HSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP claimed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed